Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill

Dose-escalated conformal radiotherapy is increasingly being used to radically treat prostate cancer with encouraging results and minimal long-term toxicity, yet little is known regarding the response of normal or malignant prostate cells to ionizing radiation (IR). To clarify the basis for cell killing during prostate cancer radiotherapy, we determined the IR-induced expression of several apoptotic- (bax, bcl-2, survivin and PARP) and G1-cell cycle checkpoint- (p53 and p21WAF1/Cip1) related proteins, in both normal (PrEC-epithelial and PrSC-stromal) and malignant (LNCaP, DU-145 and PC-3; all epithelial) prostate cells. For these experiments, we chose doses ranging from 2 to 10 Gy, to be representative of the 1.8–2 Gy daily clinical fractions given during curative radiotherapy and the 8–10 Gy single doses given in palliative radiotherapy. We observed that IR-induced bax and p21WAF1/Cip1 protein expression were attenuated selectively in normal stromal and epithelial cell cultures, yet maintained their p53-dependency in malignant cell lines. For each cell culture, we also determined total apoptotic and overall radiation cell kill using a short-term nuclear morphologic assay and a long-term clonogenic survival assay, respectively. Clonogenic survival, as measured by the surviving fraction at 2 Gy (SF2), ranged from 0.05 (PrEC) to 0.55 (DU-145), suggesting that malignant prostate cells are more radioresistant than normal prostate cells, for this series. IR-induced apoptotic cell kill was minimal (less than 6% cell after a dose of 10 Gy at times of 24–96 h) and was not dose-dependent. Furthermore, apoptotic kill was not correlated with either molecular apoptotic response or clonogenic cell kill. Using a flow cytometric proliferation assay with the PrSC (stromal) and DU-145 (epithelial) representative cultures, we observed that a senescent-like phenotype (SLP) emerges within a sub-population of cells post-irradiation that is non-clonogenic. Terminal growth arrest was dose-responsive at 96 h following irradiation and associated with long-term expression of both p21WAF1/Cip1 and p16INK4a genes. Future strategies for prostate radiotherapy prediction or novel treatments should additionally focus on terminal growth arrest as an important endpoint in prostate cancer therapy.

[1]  J. Kerr,et al.  SUCCESSIVE WAVES OF APOPTOSIS IN THE RAT PROSTATE AFTER REPEATED WITHDRAWAL OF TESTOSTERONE STIMULATION , 1984, Pathology.

[2]  Richard P. Hill,et al.  The Basic Science of Oncology , 1989 .

[3]  T. Stamey,et al.  Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts , 1989, The Prostate.

[4]  N. Kyprianou,et al.  Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death , 1989 .

[5]  N. Kyprianou,et al.  Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. , 1989, Molecular endocrinology.

[6]  T. Hsu,et al.  Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Ang,et al.  Development of apoptosis in irradiated murine tumors as a function of time and dose. , 1993, Radiation research.

[8]  E. Gelmann,et al.  p53 oncogene mutations in three human prostate cancer cell lines , 1993, The Prostate.

[9]  N. Davidson,et al.  Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. , 1993, Cancer research.

[10]  J. Leith.  In vitro radiation sensitivity of the lncap prostatic tumor cell line , 1994, The Prostate.

[11]  T. Graeber,et al.  Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. , 1995, Cancer research.

[12]  M. Arends,et al.  Increasing the susceptibility of the rat 208F fibroblast cell line to radiation-induced apoptosis does not alter its clonogenic survival dose-response. , 1995, British Journal of Cancer.

[13]  E. Rieger.  Cell proliferation and cell death in cancer , 1995 .

[14]  C C Ling,et al.  Radiation-induced apoptosis: relevance to radiotherapy. , 1995, International journal of radiation oncology, biology, physics.

[15]  A. Bergh,et al.  Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. , 1995, The American journal of pathology.

[16]  R. Lock,et al.  Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. , 1996, Cancer research.

[17]  R. Bristow,et al.  p53 protein expression or protein function? , 1996, International journal of radiation oncology, biology, physics.

[18]  R. Bristow,et al.  p53 Protein expression or protein function? Re: Awwad et al. IJROBP 34(2):323–332; 1996 , 1996 .

[19]  R. Bristow,et al.  The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  N. Kyprianou,et al.  bcl‐2 over‐expression delays radiation‐induced apoptosis without affecting the clonogenic survival of human prostate cancer cells , 1997, International journal of cancer.

[21]  C. Kurts,et al.  Class I–restricted Cross-Presentation of Exogenous Self-Antigens Leads to Deletion of Autoreactive CD8+ T Cells , 1997, The Journal of experimental medicine.

[22]  D. Altieri,et al.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[23]  R. Bristow,et al.  Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation , 1998, Oncogene.

[24]  D. Grignon,et al.  Expression of bcl-2, p53, and p21 in benign and malignant prostatic tissue before and after radiation therapy. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[25]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[26]  T. DeWeese,et al.  Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure. , 1998, The Journal of urology.

[27]  P. Carroll,et al.  Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity. , 1998, The Journal of urology.

[28]  R. Muschel,et al.  Radiation and the G2 phase of the cell cycle. , 1998, Radiation research.

[29]  B. Chauvet,et al.  [Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin]. , 1998, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[30]  V. Dulic,et al.  Differential Roles for Cyclin-Dependent Kinase Inhibitors p21 and p16 in the Mechanisms of Senescence and Differentiation in Human Fibroblasts , 1999, Molecular and Cellular Biology.

[31]  P. Olive,et al.  DNA damage and repair in individual cells: applications of the comet assay in radiobiology. , 1999, International journal of radiation biology.

[32]  M. Zelefsky,et al.  Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. , 1999, The American journal of surgical pathology.

[33]  A. Haimovitz-Friedman,et al.  Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase. , 1999, Cancer research.

[34]  F. Zindy,et al.  Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. , 1999, Cancer research.

[35]  D. Andrews,et al.  Bcl-2 targeted to the endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblasts , 1999, Oncogene.

[36]  T. Tlsty,et al.  Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light , 1999, Oncogene.

[37]  E. Kandel,et al.  A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. , 1999, Cancer research.

[38]  S. Vanderbyl,et al.  Increase in the fraction of necrotic, not apoptotic, cells in SiHa xenograft tumours shortly after irradiation. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  A. V. von Eschenbach,et al.  The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions. , 2000, International journal of radiation oncology, biology, physics.

[40]  G. Perry,et al.  Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. , 2000, International journal of radiation oncology, biology, physics.

[41]  T. McDonnell,et al.  The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo , 2000, Oncogene.

[42]  A. B. Lyons,et al.  Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe. , 2001, Methods in cell biology.

[43]  P. Marks,et al.  Inhibitors of histone deacetylase are potentially effective anticancer agents. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  A. Borkowski,et al.  Human Prostate Cancer Loss of Caspase-1 and Caspase-3 Protein Expression in Updated Version , 2001 .

[45]  Antony M. Carr,et al.  The evolution of diverse biological responses to DNA damage: insights from yeast and p53 , 2001, Nature Cell Biology.

[46]  D. Dearnaley.  Radiotherapy and combined modality approaches in localised prostate cancer. , 2001, European journal of cancer.

[47]  L Souhami,et al.  Controversies in prostate cancer radiotherapy: consensus development. , 2001, The Canadian journal of urology.

[48]  C. West,et al.  Ability to undergo apoptosis does not correlate with the intrinsic radiosensitivity (SF2) of human cervix tumor cell lines. , 2001, International journal of radiation oncology, biology, physics.

[49]  I. Roninson,et al.  Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  W. Mckenna,et al.  Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells , 2001, Oncogene.

[51]  A. V. von Eschenbach,et al.  Lack of prostate cancer radiosensitization by androgen deprivation. , 2001, International journal of radiation oncology, biology, physics.

[52]  Keiji Suzuki,et al.  Radiation-Induced Senescence-like Growth Arrest Requires TP53 Function but not Telomere Shortening , 2001, Radiation research.

[53]  I. Tannock,et al.  Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs , 2001, British Journal of Cancer.

[54]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[55]  O. Pradier,et al.  In vitro response of human dermal fibroblasts to X-irradiation: relationship between radiation-induced clonogenic cell death, chromosome aberrations and markers of proliferative senescence or differentiation , 2001, International journal of radiation biology.

[56]  D. Altieri,et al.  The molecular basis and potential role of survivin in cancer diagnosis and therapy. , 2001, Trends in molecular medicine.

[57]  Yan Shi,et al.  Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells , 2001, Oncogene.

[58]  Thea D. Tlsty,et al.  Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes , 2001, Nature.

[59]  D. Andrews,et al.  Myc Potentiates Apoptosis by Stimulating Bax Activity at the Mitochondria , 2001, Molecular and Cellular Biology.

[60]  C. Tei,et al.  Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. , 2002, International journal of cancer.

[61]  Shaun Thomas,et al.  Cell Proliferation and Cell Death , 2002 .